MAO-A inhibitors are selectively used in therapeutics for depression due to their adverse effects (Shulman et al., 2009; Menkes et al., 2016) caused by the inhibition of MAO-A in non-specific brain regions. This evidence concerns the gene MAOA and major depressive disorder.